These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29378591)

  • 1. Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection.
    Huang T; Song X; Jing J; Zhao K; Shen Y; Zhang X; Yue B
    J Nanobiotechnology; 2018 Jan; 16(1):8. PubMed ID: 29378591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccination based on pyolysin co-immunized with IL-1β enhances host antibacterial immunity against Trueperella pyogenes infection.
    Huang T; Zhao K; Zhang Z; Tang C; Zhang X; Yue B
    Vaccine; 2016 Jun; 34(30):3469-77. PubMed ID: 27091688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
    Chehelgerdi M; Doosti A
    J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier.
    Luo J; Liu XL; Zhang Y; Wang YQ; Xu WM; Yang J
    Am J Reprod Immunol; 2016 Jun; 75(6):643-53. PubMed ID: 27105782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against
    Huang T; Zhao K; Song X; Song T; Wang X; Zhang X; Yue B; Chu Y
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746448
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Zhang Y; Zhang X; Li W; Shi C; Guo C; Dai C; Chen Q; Jin Z; Zhao Y; Cui H; Wang Y
    Int J Nanomedicine; 2014; 9():389-402. PubMed ID: 24426783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence markers associated with Trueperella pyogenes infections in livestock and companion animals.
    Risseti RM; Zastempowska E; Twarużek M; Lassa H; Pantoja JCF; de Vargas APC; Guerra ST; Bolaños CAD; de Paula CL; Alves AC; Colhado BS; Portilho FVR; Tasca C; Lara GHB; Ribeiro MG
    Lett Appl Microbiol; 2017 Aug; 65(2):125-132. PubMed ID: 28561264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.
    Leya T; Ahmad I; Sharma R; Tripathi G; Kurcheti PP; Rajendran KV; Bedekar MK
    Int J Biol Macromol; 2020 Aug; 156():928-937. PubMed ID: 32289420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating effects of novel CpG chitosan-nanoparticles on immune responses of mice to porcine paratyphoid vaccines.
    Fu ML; Ying SC; Wu M; Li H; Wu KY; Yang Y; Zhang H; Cheng C; Wang ZZ; Wang XY; Lv XB; Zhang YZ; Gao R
    Biomed Environ Sci; 2006 Aug; 19(4):315-22. PubMed ID: 17044651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
    Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
    Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
    Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
    Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice.
    Liu Z; Lv D; Liu S; Gong J; Wang D; Xiong M; Chen X; Xiang R; Tan X
    PLoS One; 2013; 8(4):e60190. PubMed ID: 23577091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Shi X; Zhao Y; Wei H; Sun Q; Huang T; Zhang X; Wang Y
    Vaccine; 2011 Nov; 29(47):8549-56. PubMed ID: 21945253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of immunity of mice to Pasteurella multocida and hog cholera vaccine by pig interleukin-6 gene and CpG motifs.
    Zhao ZZ; Zhang HB; Chen Q; Su D; Xie Z; Wang YY; Yang Y; Wang ZZ; Li JL; Wu KY; Wang HN; Meng MJ; Gao R
    Comp Immunol Microbiol Infect Dis; 2009 May; 32(3):191-205. PubMed ID: 18279956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16.
    Yew JS; Ong SK; Lim HX; Tan SH; Ong KC; Wong KT; Poh CL
    Nanomedicine (Lond); 2024; 19(21-22):1779-1799. PubMed ID: 39140594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine.
    Zheng H; Pan L; Lv J; Zhang Z; Wang Y; Hu W; Liu X; Zhou P; Wang Y; Zhang Y
    Microb Pathog; 2020 Feb; 142():104061. PubMed ID: 32061916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J; zu Putlitz J; Stremmel W; Wands JR
    Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.